PARANEOPLASTIC NEUROLOGICAL SYNDROME IN A PATIENT WITH HODGKIN LYMPHOMA

  • Jelena Vulović General Hospital Paraćin, Department for Anesthesiology and Reanimation, Paraćin
  • Snežana Knežević The Academy of Applied Technical Studies Belgrade, Department of Medical Studies, Belgrade https://orcid.org/0000-0001-9137-2122
  • Marijana Jandrić-Kočić Health center Krupa na Uni, Republic Srpska, Bosnia and Hercegovina
Keywords: lymphoma, cancer, neuropathy, onconeural antibodies

Abstract


Cancer patients can develop paraneoplastic neuropathy, which cannot be explained by tumors, metastases, infections, or side effects of cancer treatment. We present a case of a 38-year-old patient of male gender with weight loss, night sweats, and weakness. He exhibited sensory loss, paresthesias, and allodynia in both lower extremities. White blood cells were 20 x 109/L, and C-reactive protein was 40 mg/L. Viral markers indicated no signs of an active infection. Ultrasonography showed several peripheral lymph nodes with reduced echogenicity. Lung computed tomography detected aggregated lymph nodes in jugular regions and mediastinum. The physical examination revealed swollen lymph nodes in the right supraclavicular region. Brain and spinal magnetic resonance were normal. Cerebrospinal fluid cytology ruled out infectious and malignant involvement. Nerve conduction studies revealed decreased amplitude in the lower extremities, with the inability to elicit sensory and motor responses. Nerve conduction studies revealed decreased amplitude in the lower extremities, with the inability to elicit sensory and motor responses and diminished F response. The patient had symmetrical, ascending neuropathy with absent deep tendon reflexes, indicating sensory-motor polyneuropathy. The biopsy of the lymph node confirmed mixed cellularity Hodgkin lymphoma. The patient started on a chemotherapy regimen including doxorubicin, bleomycin, vinblastine, and dacarbazine. Intravenous immunoglobulins were administered. Partial improvement was noted, with prolonged physical therapy. When neurological symptoms are associated with a tumor or positive onconeural antibodies, paraneoplastic neuropathy can be diagnosed. Timely recognition is crucial since any delay in treatment can be detrimental.   

Author Biography

Snežana Knežević, The Academy of Applied Technical Studies Belgrade, Department of Medical Studies, Belgrade

PhD student at Faculty of medical sciences and Faculty of Hospitality and Tourism in Vrnjačka Banja, teaching associate at the University of Kragujevac, master manager of health care, general medicine specialist in Health CenterKraljevo, family doctor, coordinator for violence against women in the Health Center, accredited educator of health workers in the field of violence in the family (UNFPA Serbia) (2019). Member of the Presidency and Scientific Board of SLD (General Medicine Section) (2019). Member of the Editorial Board of the Journal of General Medicine (2020). Author of scientific research paperss, presentations at international and domestic conferences, published in international and domestic proceedings and supplements. European winner of the Montegut global scholarship program award for contribution to primary health care (2019). Member of EGPRN, EPCCS and WONCA SIGFV. Associate on the IMOCAFV project and coordinator for the Republic of Serbia (2020). Reviewer of papers for WONCA European ConferenceS (2020 and 2021). Winner of schoolaship fees for participation in the 26th European Conference of General Practitioners and Family Medicine WONCA Europe (2021).

References

Al IO, Koç B, Bayram C, Paslı EU, Yıldız EP, Ayçiçek A, et al. Variant Guillain-Barré syndrome in a patient with Hodgkin lymphoma: AMSAN. Turk Pediatri Ars 2018;53(4):263–6.[CrossRef][PubMed]

Antoine JC, Camdessanché JP. Paraneoplastic neuropathies. Curr Opin Neurol 2017;30(5):513–20. [CrossRef][PubMed]

Flanagan EP, Sandroni P, Pittock SJ, Inwards DJ, Jones LK. Paraneoplastic lower motor neuronopathy associated with Hodgkin lymphoma. Muscle Nerve 2012;46(5):823–7.[CrossRef][PubMed]

Graus F, Ariño H, Dalmau J. Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas. Blood 2014;123(21):3230–8. [CrossRef][PubMed]

Graus F, Dalmau J. Paraneoplastic neuropathies. Curr Opin Neurol 2013;26(5):489–95.[CrossRef][PubMed]

Graus F, Vogrig A, Muñiz-Castrillo S, Antoine JCG, Desestret V, Dubey D, et al. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes. Neurol Neuroimmunol Neuroinflamm 2021;8(4):e1014. [CrossRef][PubMed]

Mauermann ML. Neurologic Complications of Lymphoma, Leukemia, and Paraproteinemias. Continuum (Minneap Minn) 2017;23(3, Neurology of Systemic Disease):669–90. [CrossRef][PubMed]

Muppidi S, Vernino S. Paraneoplastic neuropathies. Continuum (Minneap Minn) 2014;20(5, Peripheral Nervous System Disorders):1359–72.[CrossRef][PubMed]

Verschueren A. Motor neuropathies and lower motor neuron syndromes. Rev Neurol (Paris) 2017;173(5):320–5. [CrossRef][PubMed]

Zoccarato M, Grisold W, Grisold A, Poretto V, Boso F, Giometto B. Paraneoplastic Neuropathies: What’s New Since the 2004 Recommended Diagnostic Criteria. Frontiers in Neurology 2021;12:706169. [CrossRef][PubMed]

Published
2024/10/31
Section
Case report